Pancreatic Cancer Research

ResearcherInstitute of Genetics and Animal Biotechnology of the Polish Academy of SciencesActive in the last 2 years

Łukasz Szymański

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0148-541X; OpenAlex author ID A5054364185. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2024: 2 papers · 2025: none · 2026: 1 paper

Papers 3

  1. Impact of concomitant use of renin-angiotensin system inhibitors on survival in patients with pancreatic ductal adenocarcinoma: a systematic review and meta-an… Co-author DOI 10.1177/17588359251404266↗
  2. Synergistic effects of calcium channel blockers and renin-angiotensin inhibitors with gemcitabine-based chemotherapy on the survival of patients with pancreati… Co-author DOI 10.1007/s00432-024-05962-5↗
  3. Correlation Between Antihypertensive Drugs and Survival Among Patients with Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers16233945↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Leszek Kraj · 3 shared papers, 2024–2026 · strength 0.80
  2. Lucjan Stanislaw Wyrwicz · 2 shared papers, 2024 · strength 0.47
  3. Michał Peller · 1 shared paper, 2026 · strength 0.33
  4. Natalia Kluz · 1 shared paper, 2024 · strength 0.24
  5. Andrzej M. Śliwczyński · 1 shared paper, 2024 · strength 0.23
  6. Maciej Słodkowski · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.